Finance

Lists
Why is AXON up 2.71%?
Dive Deeper
AXON:NASDAQ
Axon Enterprise Inc
$315.43
+2.71%
(+8.32) 1D
$314.50
-0.29% (-0.93)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXON...
Open
$307.15
High
$318.36
Low
$301.11
Mkt. cap
25.01B
Avg. vol.
1.38M
Volume
1.27M
52-wk high
$665.06
52-wk low
$291.45
Beta
1.48
Shares outstanding
81.43M
No. of employees
5K
Open
$307.15
High
$318.36
Low
$301.11
Mkt. cap
25.01B
Avg. vol.
1.38M
Volume
1.27M
52-wk high
$665.06
52-wk low
$291.45
Beta
1.48
Shares outstanding
81.43M
No. of employees
5K
News stories
From web sources and news partners
Profile
Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians. Its initial product and former namesake is the Taser, a line of electroshock weapons. The company has since diversified into technology products for military and law enforcement, including body-worn cameras, dashcams, computer-aided dispatch software, and Evidence.com, a cloud-based digital evidence platform. As of 2017, body-worn cameras and associated services comprised a quarter of Axon's overall business. Wikipedia
About Axon Enterprise Inc
CEOPatrick W. Smith
Employees5.1K
FoundedSep 7, 1993
HeadquartersScottsdale, Arizona, United States
SectorIndustrials
IndustryAerospace and Defense
Website-
Analyst ratings
Based on 13 analysts giving stock ratings to AXON in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for AXON in the last 3 months.
Highest
Current $315.43
$750.00 (+137.77%)
Average
$549.38 (+74.17%)
Lowest
$380.00 (+20.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Latimore
Northland Securities
Buy
Maintained
$540.00
+71.2%
11/09/2026
Tim Long
Barclays
Buy
Maintained
$507.00
+60.7%
11/09/2026
Brian Gesuale
Raymond James
Buy
Reiterated
$475.00
+50.6%
11/06/2026
Andrew Spinola
UBS
Hold
Reiterated
$380.00
+20.5%
11/06/2026
Joseph Cardoso
J.P. Morgan
Buy
Maintained
$610.00
+93.4%
11/06/2026
David Paige
RBC Capital
Buy
Reiterated
$615.00
+95%
11/06/2026
Andrew Sherman
TD Cowen
Buy
Maintained
$650.00
+106.1%
11/06/2026
Meta Marshall
Morgan Stanley
Buy
Reiterated
$485.00
+53.8%
11/06/2026
Jeremy Hamblin
Craig-Hallum
Hold
Downgraded
$390.00
+23.6%
11/06/2026
William Power
Robert W. Baird
Buy
Maintained
$600.00
+90.2%
11/06/2026
James Fish
Piper Sandler
Buy
Reiterated
$540.00
+71.2%
11/06/2026
John Staszak
Argus Research
Buy
Reiterated
$600.00
+90.2%
09/02/2026
Joshua Reilly
Needham
Buy
Maintained
$750.00
+137.8%
09/02/2026
Jonathan Ho
William Blair
Buy
Maintained
-
-
08/13/2026
Michael Ng
Goldman Sachs
Buy
Maintained
$715.00
+126.7%
08/10/2026
Nilesh Bhaiya
Citi
Buy
Maintained
$715.00
+126.7%
08/06/2026
Jordan Lyonnais
Bank of America Securities
Buy
Maintained
$700.00
+121.9%
05/07/2026
Trevor J. Walsh
Citizens JMP
Buy
Maintained
$700.00
+121.9%
05/07/2026
George Notter
Wolfe Research
Buy
Maintained
$675.00
+114%
05/06/2026
Mike Ng
Goldman Sachs
Buy
Reiterated
$535.00
+69.6%
05/06/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$1.72 / $1.89
-8.94%miss
Revenue / Est. (USD)
908.55M / 934.33M
-2.76%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
796.72M
807.34M
904.39M
908.55M
Cost of goods sold
331.35M
329.89M
356.91M
393.58M
Cost of revenue
331.35M
329.89M
356.91M
393.58M
Research and development expenses
192.94M
188.95M
208.69M
192.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
294.77M
259.09M
290.98M
280.50M
Operating expense
489.78M
448.04M
500.73M
472.90M
Total operating expenses
821.13M
777.94M
857.64M
866.47M
Operating income
-24.40M
29.41M
46.75M
42.08M
Other non operating income
-38.84M
87.00K
-169.00K
95.00K
EBT including unusual items
-66.24M
200.22M
32.68M
78.92M
EBT excluding unusual items
-74.51M
9.30M
25.88M
19.18M
Income tax expense
-68.98M
30.91M
3.26M
21.91M
Effective tax rate
104.14%
15.44%
9.97%
27.77%
Other operating expenses
2.07M
-
1.06M
-
Net income
2.74M
169.31M
29.43M
57.01M
Net profit margin
0.34%
20.97%
3.25%
6.27%
Earnings per share
2.15
1.61
1.88
1.72
Interest and investment income
17.63M
10.61M
6.82M
5.66M
Interest expense
-28.82M
-28.64M
-28.10M
-28.34M
Net interest expenses
-11.19M
-18.03M
-21.29M
-22.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.54M
59.77M
79.22M
75.32M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps